SpaceX has expanded its NASA contract to include three additional crewed Dragon flights to the ISS by 2030, bringing the total to 17 operational missions under the Commercial Crew Transportation Capability contract and valuing the deal at up to $946 million.

The contract covers ground preparation, launch, in-space operations, crew return, and capsule recovery, and includes supplies and keeping the spacecraft ready as an emergency escape vehicle.

Crew 13 is planned for October and Crew 14 for the following spring, with SpaceX reportedly shifting toward a greater focus on its Starship for future missions.

Market reaction saw BA stock rise near 1% on the news, while retail sentiment on Stocktwits turned extremely bullish despite no signed deal or price details.

Risks include potential Starship test delays or failures that could trigger a technical breakdown below the 50-day moving average and dampen the bullish setup, alongside possible stalls in Starlink demand due to regulatory, pricing, or deployment challenges.

Overall investor attention remains on Starship milestones for upside potential, even as price action reflects sensitivity to launch-date changes and regulatory clearance status.

The article notes indirect implications for Indian investors and space-sector themes, emphasizing long-term commercialization of space infrastructure rather than an immediate earnings trigger for Indian companies.

Analysts expect continued revenue growth, with some projections suggesting total revenue could surpass $150 billion next year driven by Starlink monetization and data-center demand, despite volatility around Starship milestones.

The investment thesis highlights a feedback loop where increased satellite capacity could boost AI and data-center traffic, reinforcing multiple expansion for SpaceX’s SPCX.

The report includes tracking details for Starlink objects, with projected decay windows, inclinations, and conjunction risk assessments from SOCRATES, noting active reentry predictions for several satellites.

Market mood shows SpaceX trading near the mid-€130s with volatility; analysts are divided on the stock outlook, with some raising price targets while others stay neutral amid ongoing test-phase risks.

Boeing’s Starliner remains unready for routine crew flights, having cost over $2 billion and serving as a smaller, loss-making part of a larger defense-focused business.